P

Prothena Corp
D

PRTA

15.050
USD
-0.13
(-0.86%)
Market Open
Volume
6,636
EPS
-2
Div Yield
-
P/E
-6
Market Cap
813,049,941
OverviewSignalsIdeasNews
Related Instruments
    ALNY
    ALNY
    -6.265
    (-2.55%)
    239.240 USD
    B
    BLUE
    -0.74000
    (-8.72%)
    7.75000 USD
    BMY
    BMY
    -0.330
    (-0.58%)
    56.950 USD
    GILD
    GILD
    0.100
    (0.11%)
    92.670 USD
    I
    IMUX
    0.01500
    (1.46%)
    1.04000 USD
    I
    INCY
    0.390
    (0.57%)
    69.300 USD
    MRNA
    MRNA
    0.370
    (0.94%)
    39.730 USD
    REGN
    REGN
    8.80
    (1.25%)
    711.40 USD
    S
    SGEN
    0
    (0%)
    0.000000 USD
    VRTX
    VRTX
    2.98
    (0.75%)
    400.30 USD
    More
News

Title: Prothena Corp

Sector: Healthcare
Industry: Biotechnology
Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004).